BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19949938)

  • 1. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
    Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
    Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
    J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
    Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
    Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
    J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
    Piao L; Marsboom G; Archer SL
    J Mol Med (Berl); 2010 Oct; 88(10):1011-20. PubMed ID: 20820751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
    Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL
    Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
    Archer SL; Fang YH; Ryan JJ; Piao L
    Pulm Circ; 2013 Jan; 3(1):144-52. PubMed ID: 23662191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca
    Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F
    J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
    Ryan JJ; Archer SL
    Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.
    Sutendra G; Dromparis P; Paulin R; Zervopoulos S; Haromy A; Nagendran J; Michelakis ED
    J Mol Med (Berl); 2013 Nov; 91(11):1315-27. PubMed ID: 23846254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
    Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
    Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
    Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
    Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered proteasome function in right ventricular hypertrophy.
    Heitmeier T; Sydykov A; Lukas C; Vroom C; Korfei M; Petrovic A; Klingel K; Günther A; Eickelberg O; Weissmann N; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT; Meiners S; Kosanovic D
    Cardiovasc Res; 2020 Feb; 116(2):406-415. PubMed ID: 31020333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmural dispersion of repolarization and cardiac remodeling in ventricles of rabbit with right ventricular hypertrophy.
    Meedech P; Saengklub N; Limprasutr V; Kalandakanond-Thongsong S; Kijtawornrat A; Hamlin RL
    J Pharmacol Toxicol Methods; 2015; 71():129-36. PubMed ID: 25305588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
    Gao X; Zhang Z; Li X; Wei Q; Li H; Li C; Chen H; Liu C; He K
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):545-555. PubMed ID: 32141989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.